4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000209
EVP Chief Commercial Officer sold 1,531 shares at an average $427.29 ($654,188)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-07-23 | Sale | −200 | $421.62 | $84,323 | 4,391 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-07-23 | Sale | −83 | $424.63 | $35,244 | 4,308 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-07-23 | Sale | −94 | $425.99 | $40,043 | 4,214 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-07-23 | Sale | −476 | $427.36 | $203,423 | 3,738 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-07-23 | Sale | −107 | $428.52 | $45,851 | 3,631 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-07-23 | Sale | −571 | $429.60 | $245,303 | 3,060 | I |
| Open-market sales · 1,531 sh · avg $427.29 · $654,188 | |||||||
Loading xslF345X03/edgardoc.xml…